← back to search

Lin Feng

Peking University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, RNA modifications and cancer, MicroRNA in disease regulation, and Viral-associated cancers and disorders.
h-index
51
citations
8,402
works
259
NIH funding
primary concept
email

Recent publications

Delayed simvastatin treatment improves neurological recovery after cryogenic traumatic brain injury through downregulation of ELOVL1 by inhibiting mTOR signaling
Brain Research Bulletin 2024cited by 1position: middledoi
EP.11A.01 Evaluation of Six Clinical Prognostic Scores in NSCLC Patients Undergoing First Line Chemoimmunotherapy
Journal of Thoracic Oncology 2024cited by 0position: middledoi
Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance
Nature Communications 2023cited by 65position: middledoi
Oral Microbiota Alteration and Roles in Epstein-Barr Virus Reactivation in Nasopharyngeal Carcinoma
Microbiology Spectrum 2023cited by 40position: middledoi
A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening
Nature Communications 2022cited by 50position: middledoi
Knockdown of RFC4 inhibits the cell proliferation of nasopharyngeal carcinoma in vitro and in vivo
Frontiers of Medicine 2022cited by 21position: middledoi
Integrated analysis identified NPNT as a potential key regulator in tumor metastasis of hepatocellular carcinoma
Gene 2022cited by 11position: middledoi
A Low-Producing Haplotype of Interleukin-6 Disrupting CTCF Binding Is Protective against Severe COVID-19
mBio 2021cited by 43position: lastdoi
Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming
Nature Communications 2020cited by 258position: middledoi
Integrated analysis identified CAPG as a prognosis factor correlated with immune infiltrates in lower‐grade glioma
Clinical and Translational Medicine 2020cited by 13position: middledoi
14,15β-dihydroxyklaineanone inhibits HepG2 cell proliferation and migration through p38MAPK pathway
Journal of Pharmacy and Pharmacology 2020cited by 7position: middledoi
Genome sequencing analysis identifies Epstein–Barr virus subtypes associated with high risk of nasopharyngeal carcinoma
Nature Genetics 2019cited by 234position: middledoi
Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies
Theranostics 2019cited by 81position: middledoi
RETRACTED ARTICLE: Vasculogenic mimicry formation in EBV-associated epithelial malignancies
Nature Communications 2018cited by 173position: lastdoi
Oenothein B inhibits human non-small cell lung cancer A549 cell proliferation by ROS-mediated PI3K/Akt/NF-κB signaling pathway
Chemico-Biological Interactions 2018cited by 48position: middledoi
Aspirin-induced attenuation of adipogenic differentiation of bone marrow mesenchymal stem cells is accompanied by the disturbed epigenetic modification
The International Journal of Biochemistry & Cell Biology 2018cited by 26position: middledoi
Heterogeneity of tumor-infiltrating lymphocytes ascribed to local immune status rather than neoantigens by multi-omics analysis of glioblastoma multiforme
Scientific Reports 2017cited by 40position: firstdoi
Therapeutic effects of hepatocyte growth factor-overexpressing dental pulp stem cells on liver cirrhosis in a rat model
Scientific Reports 2017cited by 18position: middledoi
Restoration of a Critical Mandibular Bone Defect Using Human Alveolar Bone‐Derived Stem Cells and Porous Nano‐HA/Collagen/PLA Scaffold
Stem Cells International 2016cited by 64position: middledoi
The chemokine CXCL13 in lung cancers associated with environmental polycyclic aromatic hydrocarbons pollution
eLife 2015cited by 99position: middledoi
Polo-like kinase 3 regulates CtIP during DNA double-strand break repair in G1
The Journal of Cell Biology 2014cited by 99position: middledoi
Preeclampsia Up-Regulates Angiogenesis-Associated MicroRNA ( <i>i.e</i> ., miR-17, -20a, and -20b) That Target Ephrin-B2 and EPHB4 in Human Placenta
The Journal of Clinical Endocrinology & Metabolism 2012cited by 178position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Lichuan Wu · Guangxi University3 papers (2020–2022)Mu‐Sheng Zeng · Sun Yat-sen University3 papers (2018–2020)Bin Zhang · Harbin Medical University2 papers (2017–2018)Miao Xu · Sun Yat-sen University2 papers (2018–2019)Yumeng Zhang · Sun Yat-sen University Cancer Center2 papers (2018–2020)Jinrui Wei · Nanjing University of Chinese Medicine2 papers (2022–2022)Rui‐Hua Xu · Henan Medical University2 papers (2019–2020)Xiao-Dong Pei · Guangxi University2 papers (2018–2020)Gui-Ping He · Qilu University of Technology2 papers (2018–2019)Qi-Sheng Feng · Sun Yat-sen University2 papers (2018–2019)Guizhen Wang · Shandong University2 papers (2015–2022)Shuzhen Guan · Guangxi University2 papers (2022–2022)Lihe Jiang · Hebei Medical University2 papers (2018–2020)Wei‐Hua Jia · Sun Yat-sen University2 papers (2019–2023)Yuanbo Zhan · Harbin Medical University2 papers (2017–2018)Yi‐Xin Zeng · Sun Yat-sen University2 papers (2018–2019)Y. Wang · Hebei Medical University1 papers (2024–2024)Kaitai Zhang · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2017–2017)Songqing He · Guangxi University1 papers (2020–2020)Yuchen Jiao · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2019–2019)